Pricing recovery may be delayed
Aroma ingredient pricing remains under pressure due to a buyer's market and Chinese competition; recovery timing is uncertain.
high · management_commentaryOriental Aromatics reported Q3 FY26 revenue of ₹252 cr (+13% YoY), but EBITDA margin contracted sharply to 5.26% (down ~559 bps YoY) and PAT swung to a loss of ₹1.92 cr.
✓ Verified against BSE filing
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Aroma ingredient pricing remains under pressure due to a buyer's market and Chinese competition; recovery timing is uncertain.
high · management_commentaryMahad plant is still at 30-35% utilization and has taken longer to stabilize, with management citing geopolitical delays and longer customer approval cycles.
high · analyst_questionAnalyst noted limited e-commerce presence and lack of innovation in camper products; management declined to discuss strategy, indicating potential underperformance.
medium · analyst_question